APGE NASDAQ
Apogee Therapeutics, Inc.
1W: +0.1%
1M: +0.7%
3M: +60.4%
YTD: +78.2%
1Y: +256.8%
3Y: +478.9%
$135.07
Last traded 2026-09-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-294M
Net Income
-23.9% YoY
$-244M
Free Cash Flow
-7.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-32.5%
ROA-29.5%
ROIC-112.9%
Valuation
P/E-31.1
P/B8.5
EV/EBITDA-31.1
Leverage
Debt/Equity0.01
Current Ratio26.44
Interest Cov.-185.1x
Quality Scores
Piotroski F4/9
Altman Z41.93
Beneish M0.00